Therapeutic effects of androgens for cachexia.

Area of Science:

• Endocrinology
• Metabolic Disorders
• Pharmacology

Background:

• Cachexia is a complex wasting syndrome associated with end-stage chronic diseases like cancer, heart failure, and HIV/AIDS.
• This condition significantly diminishes patient quality of life and survival rates.
• Current therapeutic strategies have yielded limited success, with no approved drugs available.

Purpose of the Study:

• To review and analyze the existing data on the efficacy of androgens and selective androgen receptor modulators (SARMs) in treating cachexia.
• To discuss the therapeutic potential of these compounds for cachexia management.
• To identify gaps in current research and potential future directions.

Main Methods:

• Comprehensive literature search of preclinical and clinical studies.
• Analysis of data on androgen and SARM administration in cachexia models and patient populations.
• Synthesis of findings regarding efficacy, safety, and mechanisms of action.

Main Results:

• Androgens and SARMs have demonstrated potential in preclinical models to counteract muscle wasting and improve body mass.
• Clinical data, while limited, suggests some positive effects on lean body mass and physical function.
• Further research is needed to establish optimal dosing, long-term safety, and efficacy in diverse patient groups.

Conclusions:

• Androgens and SARMs represent a promising therapeutic avenue for cachexia.
• Further rigorous clinical trials are essential to validate their efficacy and safety.
• These agents may offer a valuable option for improving outcomes in patients with cachexia.